Contents Volume 17 · Issue 1 · 2023. Pages 1-171 14 articles
Atypical pituitary hormone–target tissue axis
Frontiers of Medicine 2023, Volume 17, Issue 1, Pages 1-17 doi:10.1007/s11684-022-0973-7
Frontiers of Medicine 2023, Volume 17, Issue 1, Pages 18-42 doi:10.1007/s11684-022-0976-4
The critical importance of epigenetics in autoimmune-related skin diseases
Frontiers of Medicine 2023, Volume 17, Issue 1, Pages 43-57 doi:10.1007/s11684-022-0980-8
Frontiers of Medicine 2023, Volume 17, Issue 1, Pages 58-67 doi:10.1007/s11684-022-0937-y
Frontiers of Medicine 2023, Volume 17, Issue 1, Pages 68-74 doi:10.1007/s11684-022-0955-9
Frontiers of Medicine 2023, Volume 17, Issue 1, Pages 75-84 doi:10.1007/s11684-022-0950-1
Frontiers of Medicine 2023, Volume 17, Issue 1, Pages 85-92 doi:10.1007/s11684-021-0917-7
Frontiers of Medicine 2023, Volume 17, Issue 1, Pages 93-104 doi:10.1007/s11684-021-0892-z
CD47 blockade improves the therapeutic effect of osimertinib in non-small cell lung cancer
Frontiers of Medicine 2023, Volume 17, Issue 1, Pages 105-118 doi:10.1007/s11684-022-0934-1
Frontiers of Medicine 2023, Volume 17, Issue 1, Pages 119-131 doi:10.1007/s11684-022-0949-7
Knockdown of RFC4 inhibits the cell proliferation of nasopharyngeal carcinoma and
Frontiers of Medicine 2023, Volume 17, Issue 1, Pages 132-142 doi:10.1007/s11684-022-0938-x
RGS16 regulated by let-7c-5p promotes glioma progression by activating PI3K-AKT pathway
Frontiers of Medicine 2023, Volume 17, Issue 1, Pages 143-155 doi:10.1007/s11684-022-0929-y
Frontiers of Medicine 2023, Volume 17, Issue 1, Pages 156-164 doi:10.1007/s11684-022-0932-3
Frontiers of Medicine 2023, Volume 17, Issue 1, Pages 165-171 doi:10.1007/s11684-022-0961-y